EXTON, Pa., June 7 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM - News) today announced it will present at the Goldman Sachs Twenty-Seventh Annual Global Healthcare Conference, at 7:20 P.M. EDT (4:20 P.M. PDT) on Wednesday, June 14th. The conference is being held at Ritz-Carlton Laguna Niguel, Dana Point, California.
ViroPharma’s presentation will be webcast live for investors through http://www.viropharma.com, and available for a period of 14 days following the conference.
About ViroPharma Incorporated
ViroPharma Incorporated is a biopharmaceutical company dedicated to the development and commercialization of products that address serious diseases treated by physician specialists and in hospital settings. ViroPharma commercializes Vancocin®, approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains (for prescribing information, please download the package insert at http://www.viropharma.com/docs/pulvules_pi.pdf). ViroPharma currently focuses its drug development activities in viral diseases including cytomegalovirus (CMV) and hepatitis C (HCV). For more information on ViroPharma, visit the company’s website at http://www.viropharma.com.
Source: ViroPharma Incorporated
